It reduces insulin sensitivity at the levels of adipose tissue and liver, causing an accelerated hepatic fatty acid synthesis and an increased intrahepatic fat accumulation, which consequently results in hepatic steatosis, inflammation, and fibrosis [6,44]. The gene discussed is INS; the disease is fatty liver disease.